CLINICAL_TRIALS trial_result · 2015-07-21

Clinical Trial Update: A Phase 3 Comparative Study of TAP-144-SR(6M) in Prostate Cancer Patients Previously Treated With Hormonal Therapy [Phase 3]

A Phase 3 trial evaluating TAP-144-SR(6M) in prostate cancer patients previously treated with hormonal therapy has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Takeda | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2015-07-21